Calbee Inc
TSE:2229
Calbee Inc
TSE:2229
Price:
3 123
JPY
0.74%
Market Closed
Market Cap:
418.3B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Calbee Inc
3123
+23 (+0.74%)
| 52 Week Range |
2 808
3 637
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Calbee Inc
Balance Sheet
Balance Sheet Decomposition
Calbee Inc
Calbee Inc
| Current Assets | 121.7B |
| Cash & Short-Term Investments | 51.5B |
| Receivables | 37.7B |
| Other Current Assets | 32.5B |
| Non-Current Assets | 179.1B |
| PP&E | 141.7B |
| Intangibles | 24B |
| Other Non-Current Assets | 13.4B |
| Current Liabilities | 50.3B |
| Accounts Payable | 16.6B |
| Accrued Liabilities | 4.8B |
| Short-Term Debt | 1.9B |
| Other Current Liabilities | 26.9B |
| Non-Current Liabilities | 56.1B |
| Long-Term Debt | 35B |
| Other Non-Current Liabilities | 21.1B |
Balance Sheet
Calbee Inc
Calbee Inc
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18 891
|
22 784
|
23 961
|
23 559
|
12 992
|
42 909
|
34 572
|
35 005
|
32 167
|
44 295
|
|
| Cash Equivalents |
18 891
|
22 784
|
23 961
|
23 559
|
12 992
|
42 909
|
34 572
|
35 005
|
32 167
|
44 295
|
|
| Short-Term Investments |
34 995
|
28 999
|
28 999
|
22 998
|
42 760
|
30 653
|
38 899
|
23 999
|
0
|
0
|
|
| Total Receivables |
21 114
|
23 017
|
28 567
|
41 726
|
39 728
|
29 711
|
30 444
|
32 576
|
37 010
|
54 040
|
|
| Accounts Receivables |
21 114
|
23 017
|
28 567
|
41 726
|
39 728
|
29 711
|
30 444
|
31 826
|
36 295
|
53 118
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
750
|
715
|
922
|
|
| Inventory |
8 037
|
9 268
|
9 895
|
10 748
|
11 309
|
11 205
|
14 694
|
18 001
|
23 352
|
22 208
|
|
| Other Current Assets |
6 504
|
6 857
|
6 462
|
5 325
|
5 069
|
5 221
|
4 868
|
5 590
|
6 441
|
7 310
|
|
| Total Current Assets |
89 541
|
90 925
|
97 884
|
104 356
|
111 858
|
119 699
|
123 477
|
115 171
|
98 970
|
127 853
|
|
| PP&E Net |
59 754
|
70 159
|
70 835
|
73 096
|
72 552
|
71 718
|
77 280
|
82 979
|
101 533
|
123 657
|
|
| PP&E Gross |
59 754
|
70 159
|
70 835
|
73 096
|
72 552
|
71 718
|
77 280
|
82 979
|
101 533
|
123 657
|
|
| Accumulated Depreciation |
104 837
|
108 765
|
111 927
|
115 494
|
114 824
|
119 456
|
125 597
|
133 481
|
139 783
|
149 009
|
|
| Intangible Assets |
1 836
|
3 314
|
2 865
|
2 469
|
2 016
|
2 081
|
1 979
|
2 529
|
2 710
|
2 621
|
|
| Goodwill |
2 719
|
2 245
|
1 618
|
922
|
5 688
|
10 953
|
24 518
|
23 550
|
23 222
|
22 650
|
|
| Note Receivable |
93
|
0
|
151
|
61
|
240
|
180
|
0
|
100
|
100
|
0
|
|
| Long-Term Investments |
2 113
|
2 085
|
2 102
|
2 317
|
2 224
|
1 746
|
1 986
|
2 410
|
2 599
|
3 185
|
|
| Other Long-Term Assets |
5 912
|
5 939
|
6 556
|
8 813
|
8 172
|
8 590
|
9 738
|
9 859
|
9 961
|
12 192
|
|
| Other Assets |
2 719
|
2 245
|
1 618
|
922
|
5 688
|
10 953
|
24 518
|
23 550
|
23 222
|
22 650
|
|
| Total Assets |
161 968
N/A
|
174 878
+8%
|
182 011
+4%
|
192 034
+6%
|
202 750
+6%
|
214 967
+6%
|
238 978
+11%
|
236 598
-1%
|
239 095
+1%
|
292 158
+22%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
9 387
|
10 350
|
9 668
|
9 728
|
8 987
|
9 889
|
10 160
|
11 849
|
13 553
|
12 535
|
|
| Accrued Liabilities |
3 973
|
4 323
|
4 386
|
3 980
|
4 071
|
4 700
|
5 032
|
4 718
|
5 497
|
6 722
|
|
| Short-Term Debt |
402
|
0
|
1 107
|
1 129
|
1 027
|
871
|
2 616
|
1 447
|
1 290
|
1 433
|
|
| Current Portion of Long-Term Debt |
52
|
116
|
139
|
119
|
104
|
134
|
398
|
160
|
156
|
169
|
|
| Other Current Liabilities |
20 413
|
18 680
|
21 779
|
20 449
|
19 854
|
21 039
|
24 379
|
24 085
|
25 167
|
33 616
|
|
| Total Current Liabilities |
34 227
|
33 469
|
37 079
|
35 405
|
34 043
|
36 633
|
42 585
|
42 259
|
45 663
|
54 475
|
|
| Long-Term Debt |
107
|
437
|
348
|
261
|
141
|
357
|
3 586
|
397
|
408
|
25 438
|
|
| Deferred Income Tax |
373
|
553
|
551
|
651
|
622
|
367
|
793
|
906
|
1 287
|
1 854
|
|
| Minority Interest |
9 122
|
10 541
|
6 924
|
7 284
|
6 555
|
6 390
|
7 371
|
8 078
|
8 574
|
9 335
|
|
| Other Liabilities |
8 461
|
8 950
|
8 977
|
9 050
|
7 454
|
7 978
|
9 274
|
9 578
|
9 051
|
9 305
|
|
| Total Liabilities |
52 290
N/A
|
53 950
+3%
|
53 879
0%
|
52 651
-2%
|
48 815
-7%
|
51 725
+6%
|
63 609
+23%
|
61 218
-4%
|
64 983
+6%
|
100 407
+55%
|
|
| Equity | |||||||||||
| Common Stock |
11 975
|
12 008
|
12 020
|
12 033
|
12 044
|
12 046
|
12 046
|
12 046
|
12 046
|
12 046
|
|
| Retained Earnings |
84 981
|
98 028
|
111 947
|
123 654
|
137 456
|
148 565
|
159 551
|
170 284
|
178 329
|
191 706
|
|
| Additional Paid In Capital |
11 543
|
11 572
|
4 781
|
4 775
|
4 786
|
4 779
|
4 777
|
3 232
|
3 242
|
2 514
|
|
| Unrealized Security Profit/Loss |
617
|
0
|
604
|
680
|
467
|
129
|
300
|
436
|
488
|
796
|
|
| Treasury Stock |
699
|
0
|
539
|
1 073
|
981
|
933
|
1 045
|
12 959
|
24 886
|
24 972
|
|
| Other Equity |
1 261
|
679
|
681
|
686
|
163
|
1 344
|
260
|
2 341
|
4 893
|
9 661
|
|
| Total Equity |
109 678
N/A
|
120 928
+10%
|
128 132
+6%
|
139 383
+9%
|
153 935
+10%
|
163 242
+6%
|
175 369
+7%
|
175 380
+0%
|
174 112
-1%
|
191 751
+10%
|
|
| Total Liabilities & Equity |
161 968
N/A
|
174 878
+8%
|
182 011
+4%
|
192 034
+6%
|
202 750
+6%
|
214 967
+6%
|
238 978
+11%
|
236 598
-1%
|
239 095
+1%
|
292 158
+22%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
133
|
134
|
134
|
134
|
134
|
134
|
134
|
129
|
125
|
125
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
